About Us

Support Us

Research Awards
   Award Recipients
   Apply for an Award

   Clinical Network
   Preclinical Screening

News Room
   What's New
   Advance Newsletter
   In the News
   Media Kit

   Learn from the Experts
   Clinical Trials
   Additional Resources

Contact Us


Project Awards


Investigator Institution Project

Cameron Brennan, MD


Memorial Sloan-Kettering Cancer Center


Identification of fusion kinases as potential therapeutic targets in malignant astrocytoma and oligodendroglioma including malignant glioma

Alan D'Andrea, MD


Dana-Farber Cancer Institute


Inhibitors of the fanconi anemia Pathway as Chemosensitizing Agents for 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU) in the Treatment of Brain Tumors

Ingo Mellinghoff, MD


University of California Los Angeles


A Genome-Wide View of mTOR Dependence in GBM

Paul Mischel, MD


Univerisity of California Los Angeles


Development of a microPLC for molecular diagnosis of Glioblastoma

Jeremy Rich, MD


Duke University


Targeting DNA Damage Checkpoint Signaling in Glioma Radioresistance

Axel Schönthal, PhD


University of Southern California


Flouting COX-2: Applying the COX-2-Independent Anti-Tumor Efficacy of Celebrex to the Therapy of Glioblastoma

Angela van Tilborg, PhD


University of Amsterdam


Protein kinase target profiling and ex vivo target validation to identify efficacious inhibitors for malignant glioma

WK Alfred Yung, MD


University of Texas/MD Anderson Cancer Center


Evaluation of Small Molecule Inhibitors of the P13K/AKT Pathway

Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.